Content area

Abstract

Background: Protease inhibitors have been considered as possible therapeutic agents for COVID-19 patients.

Objectives: To describe the association between lopinavir/ritonavir (LPV/r) or darunavir/cobicistat (DRV/c) use and in-hospital mortality in COVID-19 patients.

Study Design: Multicenter observational study of COVID-19 patients admitted in 33 Italian hospitals. Medications, preexisting conditions, clinical measures, and outcomes were extracted from medical records. Patients were retrospectively divided in three groups, according to use of LPV/r, DRV/c or none of them. Primary outcome in a time-to event analysis was death. We used Cox proportional-hazards models with inverse probability of treatment weighting by multinomial propensity scores.

Results: Out of 3,451 patients, 33.3% LPV/r and 13.9% received DRV/c. Patients receiving LPV/r or DRV/c were more likely younger, men, had higher C-reactive protein levels while less likely had hypertension, cardiovascular, pulmonary or kidney disease. After adjustment for propensity scores, LPV/r use was not associated with mortality (HR = 0.94, 95% CI 0.78 to 1.13), whereas treatment with DRV/c was associated with a higher death risk (HR = 1.89, 1.53 to 2.34, E-value = 2.43). This increased risk was more marked in women, in elderly, in patients with higher severity of COVID-19 and in patients receiving other COVID-19 drugs.

Conclusions: In a large cohort of Italian patients hospitalized for COVID-19 in a real-life setting, the use of LPV/r treatment did not change death rate, while DRV/c was associated with increased mortality. Within the limits of an observational study, these data do not support the use of LPV/r or DRV/c in COVID-19 patients.

Details

1009240
Location
Title
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study
Author
Augusto Di Castelnuovo 1 ; Costanzo, Simona 2 ; Antinori, Andrea 3 ; Berselli, Nausicaa 4 ; Blandi, Lorenzo 5 ; Bonaccio, Marialaura 2 ; Bruno, Raffaele 6 ; Cauda, Roberto 7 ; Gialluisi, Alessandro 2 ; Guaraldi, Giovanni 8 ; Menicanti, Lorenzo 5 ; Mennuni, Marco 9 ; My, Ilaria 10 ; Parruti, Agostino 11 ; Patti, Giuseppe 9 ; Perlini, Stefano 12 ; Santilli, Francesca 13 ; Signorelli, Carlo 14 ; Stefanini, Giulio G 10 ; Vergori, Alessandra 15 ; Ageno, Walter 16 ; Aiello, Luca 17 ; Agostoni, Piergiuseppe 18 ; Samir Al Moghazi 19 ; Arboretti, Rosa 20 ; Aucella, Filippo 21 ; Barbieri, Greta 22 ; Barchitta, Martina 23 ; Bartoloni, Alessandro 24 ; Bologna, Carolina 25 ; Bonfanti, Paolo 26 ; Caiano, Lucia 16 ; Carrozzi, Laura 27 ; Cascio, Antonio 28 ; Castiglione, Giacomo 29 ; Chiarito, Mauro 10 ; Ciccullo, Arturo 30 ; Cingolani, Antonella 7 ; Cipollone, Francesco 13 ; Colomba, Claudia 28 ; Colombo, Crizia 9 ; Crosta, Francesco 11 ; Dalena, Giovanni 31 ; Chiara Dal Pra 32 ; Danzi, Gian Battista 33 ; D'Ardes, Damiano 13 ; Katleen de Gaetano Donati 30 ; Francesco Di Gennaro 34 ; Giuseppe Di Tano 33 ; D'Offizi, Gianpiero 35 ; Filippini, Tommaso 4 ; Fusco, Francesco Maria 36 ; Gaudiosi, Carlo 37 ; Gentile, Ivan 38 ; Gini, Giancarlo 16 ; Grandone, Elvira 21 ; Guarnieri, Gabriella 39 ; Lamanna, Gennaro L F 31 ; Larizza, Giovanni 31 ; Leone, Armando 40 ; Lio, Veronica 9 ; Losito, Angela Raffaella 30 ; Maccagni, Gloria 33 ; Maitan, Stefano 17 ; Mancarella, Sandro 41 ; Manuele, Rosa 42 ; Mapelli, Massimo 18 ; Maragna, Riccardo 18 ; Marra, Lorenzo 40 ; Maresca, Giulio 43 ; Marotta, Claudia 34 ; Mastroianni, Franco 31 ; Mazzitelli, Maria 44 ; Mengozzi, Alessandro 22 ; Menichetti, Francesco 22 ; Milic, Jovana 8 ; Minutolo, Filippo 45 ; Molena, Beatrice 39 ; Mussinelli, R 46 ; Mussini, Cristina 8 ; Musso, Maria 47 ; Odone, Anna 14 ; Olivieri, Marco 48 ; Pasi, Emanuela 49 ; Perroni, Annalisa 13 ; Petri, Francesco 50 ; Pinchera, Biagio 38 ; Pivato, Carlo A 10 ; Poletti, Venerino 51 ; Ravaglia, Claudia 51 ; Rossato, Marco 32 ; Rossi, Marianna 50 ; Sabena, Anna 52 ; Salinaro, Francesco 52 ; Sangiovanni, Vincenzo 36 ; Sanrocco, Carlo 11 ; Scorzolini, Laura 53 ; Sgariglia, Raffaella 41 ; Simeone, Paola Giustina 11 ; Spinicci, Michele 24 ; Trecarichi, Enrico Maria 44 ; Veronesi, Giovanni 16 ; Vettor, Roberto 32 ; Vianello, Andrea 39 ; Vinceti, Marco 54 ; Visconti, Elena 30 ; Vocciante, Laura 43 ; De Caterina, Raffaele 27 ; Iacoviello, Licia 55 

 Mediterranea Cardiocentro, Napoli, Italy 
 Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Italy 
 UOC Immunodeficienze Virali, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Roma, Italy 
 Section of Public Health, Department of Biomedical, Metabolic and Neural Sciences, University of Modena, Modena, Italy 
 IRCCS Policlinico San Donato, San Donato Milanese, Italy 
 Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, Department of Clinical, Surgical, Diagnostic, and Paediatric Sciences, University of Pavia, Pavia, Italy 
 Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy, Università Cattolica del Sacro Cuore- Dipartimento di Sicurezza e Bioetica Sede di Roma, Roma, Italy 
 Infectious Disease Unit, Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Modena, Italy 
 University of Eastern Piedmont, Maggiore della Carità Hospital, Novara, Italy 
10  Humanitas Clinical and Research Hospital IRCCS, Rozzano, Italy 
11  Department of Infectious Disease, Azienda Sanitaria Locale (AUSL) di Pescara, Pescara, Italy 
12  Emergency Department, IRCCS Policlinico San Matteo Foundation, Pavia, Italy, Department of Internal Medicine, University of Pavia, Pavia, Italy 
13  Department of Medicine and Aging, Clinica Medica, SS. Annunziata Hospital and University of Chieti, Chieti, Italy 
14  School of Medicine, Vita-Salute San Raffaele University, Milano, Italy 
15  HIV/AIDS Department, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Roma, Italy 
16  Department of Medicine and Surgery, University of Insubria, Varese, Italy 
17  UOC, Anestesia e Rianimazione, Dipartimento di Chirurgia Generale Ospedale Morgagni-Pierantoni, Forlì, Italy 
18  Centro Cardiologico Monzino IRCCS, Milano, Italy, Cardiovascular Section, Department of Clinical Sciences and Community Health, University of Milano, Milano, Italy 
19  UOC Infezioni Sistemiche dell'Immunodepresso, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy 
20  Department of Civil Environmental and Architectural Engineering, University of Padova, Padova, Italy 
21  Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy 
22  Department of Clinical and Experimental Medicine, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Pisa, Italy 
23  Department of Medical and Surgical Sciences and Advanced Technologies G.F. Ingrassia, University of Catania, Catania, Italy 
24  Department of Experimental and Clinical Medicine, University of Florence and Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy 
25  Ospedale del Mare, ASL Napoli 1, Napoli, Italy 
26  UOC Malattie Infettive, Ospedale San Gerardo, ASST Monza, Monza, Italy, School of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy 
27  Cardiovascular and Thoracic Department, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Pisa, Italy 
28  Infectious and Tropical Diseases Unit- Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE) - University of Palermo, Palermo, Italy 
29  Servizio di Anestesia e Rianimazione II UO Rianimazione Ospedale San Marco, AOU Policlinico-Vittorio Emanuele, Catania, Italy 
30  Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy 
31  COVID-19 Unit, EE Ospedale Regionale F. Miulli, Acquaviva delle Fonti, Italy 
32  Clinica Medica 3, Department of Medicine - DIMED, University Hospital of Padova, Padova, Italy 
33  Department of Cardiology, Ospedale di Cremona, Cremona, Italy 
34  Medical Direction, IRCCS Neuromed, Pozzilli, Italy 
35  UOC Malattie Infettive-Epatologia, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Roma, Italy 
36  UOC Infezioni Sistemiche e dell'Immunodepresso, Azienda Ospedaliera dei Colli, Ospedale Cotugno, Napoli, Italy 
37  Ospedale di Boscotrecase - ASL Napoli 3, Napoli, Italy 
38  Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy 
39  Respiratory Pathophysiology Division, Department of Cardiologic, Thoracic and Vascular Sciences, University of Padova, Padova, Italy 
40  UOC di Pneumologia, P.O. San Giuseppe Moscati, Taranto, Italy 
41  ASST Milano Nord - Ospedale Edoardo Bassini Cinisello Balsamo, Milan, Italy 
42  UOC Malattie Infettive e Tropicali, P.O. San Marco, AOU Policlinico-Vittorio Emanuele, Catania, Italy 
43  UOC di Medicina - Presidio Ospedaliero S.Maria di Loreto Nuovo, Napoli, Italy 
44  Infectious and Tropical Diseases Unit, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy 
45  Dipartimento di Farmacia, Università di Pisa, Pisa, Italy 
46  Department of Internal Medicine, University of Pavia, Pavia, Italy 
47  UOC Malattie Infettive-Apparato Respiratorio, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Roma, Italy 
48  Computer Service, University of Molise, Campobasso, Italy 
49  Medicina Interna. Ospedale di Ravenna, AUSL della Romagna, Ravenna, Italy 
50  UOC Malattie Infettive, Ospedale San Gerardo, ASST Monza, Monza, Italy 
51  UOC Pneumologia, Dipartimento di Malattie Apparato Respiratorio e Torace, Ospedale Morgagni-Pierantoni, Forlì, Italy 
52  Emergency Department, IRCCS Policlinico San Matteo Foundation, Pavia, Italy 
53  UOC Malattie Infettive ad Alta Intensità di Cura, National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy 
54  Section of Public Health, Department of Biomedical, Metabolic and Neural Sciences, University of Modena, Modena, Italy, Department of Epidemiology, Boston University School of Public Health, Boston, MA, United States 
55  Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Italy, Department of Medicine and Surgery, University of Insubria, Varese, Italy 
Publication title
Volume
8
First page
639970
Number of pages
12
Publication year
2021
Publication date
Jun 2021
Publisher
Frontiers Media SA
Place of publication
Lausanne
Country of publication
Switzerland
Publication subject
e-ISSN
2296858X
Source type
Scholarly Journal
Language of publication
English
Document type
Journal Article
Publication history
 
 
Online publication date
2021-06-09
Milestone dates
2020-12-10 (Recieved); 2021-05-05 (Accepted)
Publication history
 
 
   First posting date
09 Jun 2021
ProQuest document ID
3272709870
Document URL
https://www.proquest.com/scholarly-journals/lopinavir-ritonavir-darunavir-cobicistat/docview/3272709870/se-2?accountid=208611
Copyright
© 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Last updated
2025-11-19
Database
3 databases
  • Coronavirus Research Database
  • ProQuest One Academic
  • ProQuest One Academic